Socio-economic inequality of utilization of cancer testing in Europe: A cross-sectional study von Bozhar, H., McKee, M., Spadea, T., Veerus, P., Heinävaara, S., Anttila, A., Senore, C., Zielonke, N., de Kok, I.M.C.M., van Ravesteyn, N.T., Lansdorp-Vogelaar, I., de Koning, H.J., Heijnsdijk, E.A.M.

Volltext

Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening von Ripping, T.M, Verbeek, A.L.M, ten Haaf, K, van Ravesteyn, N.T, Broeders, M.J.M

Volltext

Reply to Koleva-Kolarova et al von de Koning, H.J, Alagoz, O, Schechter, C.B, van Ravesteyn, N.T

Volltext

Cumulative risks of false positive recall and screen detected breast cancer after multiple rounds of screening von Kregting, L., van Ravesteyn, N.T., Chootipongchaivat, S., Heijnsdijk, E.A.M., Otten, J.D.M., Broeders, M.J.M., de Koning, H.J.

Volltext

Effects of cancer screening restart strategies after COVID-19 disruption von Kregting, L., Kaljouw, S., de Jonge, L., Jansen, E.E.L., Peterse, E.F.P., Heijnsdijk, E.A.M., van Ravesteyn, N.T., Lansdorp-Vogelaar, I., de Kok, I.M.C.M.

Volltext

2N Model based predictions show higher mortality reduction for the UK Breast Screening Frequency Trial: no definitive answer on the optimal screening frequency von van Ravesteyn, N.T, Heijnsdijk, E.A, Draisma, G, de Koning, H.J

Volltext

Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands von Ripping, T.M., Verbeek, A.L.M., Fracheboud, J., de Koning, H.J., van Ravesteyn, N.T., Broeders, M.J.M.

Volltext

Authors' reply to: “Questionable method for estimating the influence of mammography screening on breast cancer mortality in the Netherlands” von Sankatsing, V.D.V., van Ravesteyn, N.T., Heijnsdijk, E.A.M., de Koning, H.J.

Volltext

Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands: Overdiagnosis in birth cohorts von Ripping, T.M., Verbeek, A.L.M., Fracheboud, J., de Koning, H.J., van Ravesteyn, N.T., Broeders, M.J.M.

Volltext

The early detection of breast cancer using liquid biopsies: model estimates of the benefits, harms, and costs von Poort, E.K.J. van der, Ravesteyn, N.T. van, Broek, J.J. van den, Koning, H.J. de

Volltext bestellen

Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: follow-up results of the TRIDENT-2 study von Schuurman, L.V., Sistermans, E.A., Opstal, D. van, Henneman, L., Bekker, M.N., Bax, C.J., Pieters, M.J., Bouman, K., Munnik, S. de, Hollander, N.S. den, Diderich, K.E.M., Faas, B.H.W., Feenstra, I., Go, A.T.J.I., Hoffer, M.J.V., Joosten, M., Komdeur, F.L., Lichtenbelt, K.D., Lombardi, M.P., Polak, M.G., Jehee, F.S., Schuring-Blom, H., Stevens, S.J.C., Srebniak, M.I., Suijkerbuijk, R.F., Tan-Sindhunata, G.M., Meij, K.R.M. van der, Maarle, M.C. van, Vernimmen, V., Zelderen-Bhola, S.L. van, Ravesteyn, N.T. van, Knapen, M.F.C.M., Macville, M.V.E., Galjaard, R.J.H.

Volltext bestellen